GlassScriptPhysician profile
Kaitlin Ridder
NPI 1114339447
$12,410.99
in general payments reported to CMS, 2019-2025
46 companies · $3,360 in 2025
The $3,360 reported for 2025 was more than what 88% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $356 · 2020: $239 · 2021: $476 · 2022: $2,066 · 2023: $2,669 · 2024: $3,245 · 2025: $3,360.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $9,029 · Education: $244.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $9,029.18 |
| Education | $244.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dendreon Pharmaceuticals LLC | $1,969.22 | 2019-2025 | Provenge |
| Medtronic, INC. | $1,727.65 | 2022-2024 | Interstim |
| Janssen Biotech, INC. | $1,030.79 | 2022-2025 | Erleada |
| Sumitomo Pharma America, INC. | $983.30 | 2023-2025 | Gemtesa, Orgovyx |
| Astellas Pharma US INC | $804.21 | 2019-2025 | Xtandi, Veozah, Myrbetriq |
| Bayer Healthcare Pharmaceuticals INC. | $510.96 | 2022-2025 | |
| Antares Pharma, INC. | $497.81 | 2021-2025 | Xyosted, Nocdurna, Tlando |
| Pfizer INC. | $434.12 | 2023-2025 | |
| Accord Healthcare, INC. | $359.45 | 2022-2025 | |
| Abbvie INC. | $322.66 | 2020-2025 | |
| 180 Medical, INC. | $305.97 | 2021-2025 | Gentlecath, Gentlecath Glide, Cure Ultra Catheter |
| Urogen Pharma, INC. | $299.62 | 2023-2025 | Jelmyto |
| Renovia INC | $270.29 | 2019-2020 | |
| Immunitybio, INC. | $244.15 | 2024-2025 | |
| Endo USA, INC. | $234.79 | 2024-2025 | Xiaflex, Aveed |
Show all 46 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ferring Pharmaceuticals INC. | $221.64 | 2024-2025 | Adstiladrin |
| Urovant Sciences INC | $220.10 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $192.14 | 2020-2025 | Keytruda, Lynparza, Welireg |
| Boston Scientific Corporation | $189.32 | 2019-2025 | Spaceoar Vue System - 10ml, Axonics |
| Myovant Sciences INC. | $152.90 | 2021-2022 | |
| Procept Biorobotics Corporation | $143.96 | 2023-2025 | Aquabeam System, Aquabeam Robotic System |
| Coloplast Corp | $143.80 | 2024-2025 | |
| Laborie Medical Technologies Corp. | $99.94 | 2023 | |
| Novartis Pharmaceuticals Corporation | $91.27 | 2024-2025 | |
| Angiodynamics, INC. | $90.86 | 2022-2024 | Nanoknife |
| Astrazeneca Pharmaceuticals LP | $76.46 | 2022-2024 | Lynparza, Wainua |
| Endo Pharmaceuticals INC. | $71.65 | 2020-2024 | Xiaflex, Aveed |
| Halozyme INC | $67.31 | 2023 | |
| Smith+Nephew, INC. | $62.77 | 2024-2025 | Stravix |
| Tolmar, INC. | $61.63 | 2023-2024 | |
| Axonics, INC. | $56.33 | 2022-2023 | Axonics |
| Verity Pharmaceuticals INC. | $52.24 | 2025 | Trelstar, Tlando |
| Lumenis, INC | $49.33 | 2021 | |
| Tempus Ai, INC | $48.57 | 2025 | Xt Cdx |
| Progenics Pharmaceuticals, INC. | $37.64 | 2024 | |
| Palette Life Sciences, INC. | $37.61 | 2022 | |
| Telix Pharmaceuticals | $37.32 | 2024-2025 | Illuccix |
| Blue Earth Diagnostics | $37.25 | 2022-2023 | |
| Olympus America INC. | $35.88 | 2021-2025 | Itind System |
| Sun Pharmaceutical Industries INC. | $34.02 | 2022-2023 | Yonsa |
| Tolmar Pharmaceuticals, INC. | $22.55 | 2021 | |
| Abc Home Medical Supply, INC. | $19.96 | 2025 | |
| Cardinal Health 414 LLC | $17.88 | 2024 | |
| Calyxo, INC. | $17.53 | 2024 | Cvac Aspiration System |
| Kowa Pharmaceuticals America, INC. | $13.20 | 2023 | Seglentis |
| Photocure INC | $12.94 | 2023 | Cysview |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kaitlin Ridder listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.